$274.65
93886 reports the complete intracranial TCD examination; 93896 adds the vasoreactivity assessment and requires a primary procedure.
On this page
CMS RVU26D · Effective 2026-10-01
93896 TCD vasoreactivity Medicare reimbursement rates in Minnesota
Reports a complete transcranial Doppler vasoreactivity assessment of intracranial arteries, performed with a primary TCD procedure to evaluate cerebrovascular response. Compare 93896 office and facility rates across CMS payment localities in Minnesota.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 93896 in Minnesota?
Minnesota has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$190.09
1 of 1 localities have a supported rate.
Payment area: Minnesota
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Vascular ultrasound
About 93896: Complete TCD vasoreactivity study
Reports a complete transcranial Doppler vasoreactivity assessment of intracranial arteries, performed with a primary TCD procedure to evaluate cerebrovascular response.
This service adds a complete cerebral vasoreactivity assessment using transcranial Doppler (TCD), which measures changes in blood-flow velocity in intracranial arteries during a vasodilatory challenge. Vascular laboratories and neurology services may perform it when evaluating cerebrovascular reserve, including in patients with suspected impaired autoregulation or intracranial arterial disease. The assessment evaluates the response across a complete intracranial TCD examination, rather than documenting baseline flow alone.
Report 93896 only with its required primary TCD procedure; it is an add-on, not a stand-alone service. For a complete intracranial TCD study, the primary procedure is generally 93886. Documentation should identify the arteries assessed, the challenge and response measurements, and the interpretation supporting a complete vasoreactivity evaluation. CMS payment is included within the primary procedure's global period. Modifier 26 identifies the professional interpretation, modifier TC identifies the technical service, and no component modifier represents the global service.
CMS billing rules for 93896
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Diagnostic test with a professional component (modifier 26, interpretation) and a technical component (modifier TC, equipment and staff); billing without a modifier is the global service.
Where the value comes from
- Work RVU0.79 · 14%
- Practice expense (office) RVU4.74 · 84%
- Malpractice RVU0.08 · 1%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
93896 compared with similar codes
Office rates for Minnesota, from the same CMS release.
93888
No office rateIntracranial limited study
93888 is for a limited intracranial TCD examination. Use 93896 for the complete vasoreactivity add-on, not as a substitute for the limited study.
93892
No office rateTcd emboli detect w/o inj
93892 evaluates embolic signals. Code 93896 assesses intracranial flow response to a vasodilatory challenge.
Compare 93896 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Minnesota →
Office / nonfacility
$190.09
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 93896 in Minnesota.
PPRRVU2026_Oct_nonQPP.csv
12,296
- Code
- 93896
- Physician work
- 0.79
- Practice expense
- 4.74
- Malpractice
- 0.08
GPCI2026.csv
66
- Locality
- Minnesota
- Physician work
- 1.000
- Practice expense
- 1.029
- Malpractice
- 0.296
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.79 | × 1.000 | 0.7900 |
| Practice expense | 4.74 | × 1.029 | 4.8775 |
| Malpractice | 0.08 | × 0.296 | 0.0237 |
| Total RVUs | 5.6911 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Minnesota$190.09
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0.79 | 1 |
| Practice expense | 4.74 | 1.029 |
| Malpractice | 0.08 | 0.296 |
(0.79 × 1 + 4.74 × 1.029 + 0.08 × 0.296) × $33.4009 = $190.09
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
93896 billing questions
Can 93896 be reported by itself?
No. It is an add-on and must be reported with a primary procedure; a complete intracranial TCD study is generally reported with 93886.
How is 93896 different from 93886?
93886 represents the complete intracranial TCD study. Code 93896 adds the vasoreactivity assessment to that primary study.
Which modifiers identify the components?
Use modifier 26 for the professional interpretation and TC for the technical service. Submit without a component modifier when billing the global service.
What documentation supports a complete vasoreactivity study?
Document the intracranial arteries assessed, the vasodilatory challenge and resulting flow-velocity measurements, and the interpretation of the response.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
12,29393895,,Carotid intima atheroma eval,N,,0.00,0.00,,0.00,NA,0.00,0.00,0.00,1,XXX,0.00,0.00,0.00,6,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,29493895,26,Carotid intima atheroma eval,N,,0.00,0.00,,0.00,,0.00,0.00,0.00,1,XXX,0.00,0.00,0.00,6,0,0,0,0,9,,33.4009,01,0,99,0.00,0.00,0.00
12,29593895,TC,Carotid intima atheroma eval,N,,0.00,0.00,,0.00,NA,0.00,0.00,0.00,1,XXX,0.00,0.00,0.00,6,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,29693896,,Vsrctv std tcd icr art compl,A,,0.79,4.74,,4.74,NA,0.08,5.61,5.61,1,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,29793896,26,Vsrctv std tcd icr art compl,A,,0.79,0.38,,0.38,,0.06,1.23,1.23,1,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,29893896,TC,Vsrctv std tcd icr art compl,A,,0.00,4.36,,4.36,NA,0.02,4.38,4.38,1,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,01,0,99,0.00,0.00,0.00
12,29993897,,Emboli detcj wo iv mbubb njx,A,,0.71,6.32,,6.32,NA,0.08,7.11,7.11,1,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
6314212,MA,99,REST OF MASSACHUSETTS,1.016,1.053,0.797
6408202,MI,01,DETROIT,1.000,0.965,1.686
6508202,MI,99,REST OF MICHIGAN,1.000,0.913,1.129
6606202,MN,00,MINNESOTA,1.000,1.029,0.296
6707302,MS,00,MISSISSIPPI,1.000,0.861,0.739
6805302,MO,02,METROPOLITAN KANSAS CITY,1.000,0.939,0.977
6905302,MO,01,METROPOLITAN ST. LOUIS,1.000,0.952,1.002